Intangible Assets and Goodwill (Tables)

12 Months Ended

Dec. 31, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets

The following information details the carrying amounts and accumulated amortization of the Company’s intangible assets subject to amortization:

		As of December 31, 2013							As of December 31, 2012
	Weighted Average Useful Life	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
	(In thousands)
Amortizable intangible assets
Customer relationships(1)	8 years	$	7,457	$	(5,631	)	$	1,826	$	7,457	$	(4,106	)	$	3,351
Selling rights agreements(1)	5.7 years	9,125		(5,870		)	3,255		9,125		(3,469		)	5,656
Trademarks(1)	8 years	3,024		(2,284		)	740		3,024		(1,665		)	1,359
Product licenses(2)	5.7 years	71,530		(25,067		)	46,463		39,000		(1,129		)	37,871
Cleviprex milestones(3)	13 years	2,000		(191		)	1,809		2,000		(161		)	1,839
Total	6.1 years	$	93,136	$	(39,043	)	$	54,093	$	60,606	$	(10,530	)	$	50,076

_______________________________________

(1) The Company amortizes intangible assets related to Angiox through the end of its patent life.

(2) The Company amortizes intangible assets related to the product licenses over their expected useful lives.

(3) The Company amortizes intangible assets related to the Cleviprex approval over the remaining life of the patent.

Schedule of Indefinite-lived Intangible Assets

The following information details the carrying amounts of the Company’s intangible assets not subject to amortization:

	As of December 31, 2013						As of December 31, 2012
	Gross Carrying Amount		Adjustments		Net Carrying Amount		Gross Carrying Amount		Adjustments		Net Carrying Amount
	(In thousands)
Intangible assets not subject to amortization:
In-process research and development	$	720,180	$	—	$	720,180	69,500		$	—	$	69,500
Recothrom option	62,000		—		62,000		—		—		—
Total	$	782,180	$	—	$	782,180	$	69,500	$	—	$	69,500

Schedule of Goodwill

The changes in in the carrying amount of goodwill for the years ended December 31, 2013 and December 31, 2012 are as follows:

	December 31, 2013			December 31, 2012
	(In thousands)
Balance at beginning of period	$	14,671		$	14,671
Goodwill resulting from the acquisition of Incline	102,613			—
Goodwill resulting from the acquisition of Recothrom	21,000			—
Goodwill resulting from the acquisition of ProFibrix	52,037			—
Goodwill resulting from the acquisition of Rempex	68,570			—
Translation adjustments	(1,197		)	—
Balance at end of period	$	257,694		$	14,671